803 related articles for article (PubMed ID: 19420236)
1. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function.
Seebach J; Mädler HJ; Wojciak-Stothard B; Schnittler HJ
Thromb Haemost; 2005 Sep; 94(3):620-9. PubMed ID: 16268481
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
Friedl J; Turner E; Alexander HR
Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in cultured endothelial cells by a cadherin antagonist peptide: involvement of fibroblast growth factor receptor-mediated signalling.
Erez N; Zamir E; Gour BJ; Blaschuk OW; Geiger B
Exp Cell Res; 2004 Apr; 294(2):366-78. PubMed ID: 15023527
[TBL] [Abstract][Full Text] [Related]
6. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro.
Schlegel N; Baumer Y; Drenckhahn D; Waschke J
Crit Care Med; 2009 May; 37(5):1735-43. PubMed ID: 19325485
[TBL] [Abstract][Full Text] [Related]
8. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo.
Fürst R; Bubik MF; Bihari P; Mayer BA; Khandoga AG; Hoffmann F; Rehberg M; Krombach F; Zahler S; Vollmar AM
Mol Pharmacol; 2008 Jul; 74(1):1-8. PubMed ID: 18413663
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of VE-cadherin proteasomal degradation attenuates microvascular hyperpermeability.
Sawant DA; Tharakan B; Adekanbi A; Hunter FA; Smythe WR; Childs EW
Microcirculation; 2011 Jan; 18(1):46-55. PubMed ID: 21166925
[TBL] [Abstract][Full Text] [Related]
11. Effect of sphingosine 1-phosphate on morphological and functional responses in endothelia and venules after scalding injury.
Liu X; Wu W; Li Q; Huang X; Chen B; Du J; Zhao K; Huang Q
Burns; 2009 Dec; 35(8):1171-9. PubMed ID: 19520517
[TBL] [Abstract][Full Text] [Related]
12. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells.
Blecharz KG; Drenckhahn D; Förster CY
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1139-49. PubMed ID: 18231113
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin).
Caveda L; Martin-Padura I; Navarro P; Breviario F; Corada M; Gulino D; Lampugnani MG; Dejana E
J Clin Invest; 1996 Aug; 98(4):886-93. PubMed ID: 8770858
[TBL] [Abstract][Full Text] [Related]
15. Plasmalemmal concentration and affinity of mouse vascular endothelial cadherin, VE-cadherin.
Baumgartner W; Drenckhahn D
Eur Biophys J; 2002 Dec; 31(7):532-8. PubMed ID: 12451422
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
17. Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin.
Park KS; Schecterson L; Gumbiner BM
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1403-H1410. PubMed ID: 33577432
[TBL] [Abstract][Full Text] [Related]
18. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
[TBL] [Abstract][Full Text] [Related]
19. Beyond vessels: occurrence and regional clustering of vascular endothelial (VE-)cadherin-containing junctions in non-endothelial cells.
Boda-Heggemann J; Régnier-Vigouroux A; Franke WW
Cell Tissue Res; 2009 Jan; 335(1):49-65. PubMed ID: 19002500
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 opens endothelial cell junctions by targeting catenins.
Kronstein R; Seebach J; Grossklaus S; Minten C; Engelhardt B; Drab M; Liebner S; Arsenijevic Y; Taha AA; Afanasieva T; Schnittler HJ
Cardiovasc Res; 2012 Jan; 93(1):130-40. PubMed ID: 21960684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
